175 related articles for article (PubMed ID: 30340636)
21. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
22. Sarcoma Risk in Uterine Surgery in a Tertiary University Hospital in Germany.
Kundu S; Zachen M; Hertel H; Hillemanns P; Soergel P
Int J Gynecol Cancer; 2017 Jun; 27(5):961-966. PubMed ID: 28498262
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.
Von Bargen EC; Grimes CL; Mishra K; Wang R; Haviland MJ; Hacker MR; Carnevale JA; Estes AJ; Elkadry EA
Int J Gynaecol Obstet; 2017 May; 137(2):123-128. PubMed ID: 28170091
[TBL] [Abstract][Full Text] [Related]
24. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
25. Utilization of preoperative imaging in uterine cancer patients.
Gien LT; Barbera L; Kupets R; Saskin R; Paszat L
Gynecol Oncol; 2009 Nov; 115(2):226-30. PubMed ID: 19683807
[TBL] [Abstract][Full Text] [Related]
26. Proportion of Uterine Malignant Tumors in Patients with Laparoscopic Myomectomy: A National Multicenter Study in China.
Yang H; Li XC; Yao C; Lang JH; Jin HM; Xi MR; Wang G; Wang LW; Hao M; Ding Y; Chen J; Zhang JQ; Han L; Guo CX; Xue X; Li Y; Zheng JH; Cui MH; Li HF; Tao GS; Chen L; Wang SM; Lu AW; Huang ZH; Liu Q; Zhuang YL; Huang XH; Zhu GH; Huang OP; Hu LN; Li MJ; Zhou HL; Song JH; Zhu L
Chin Med J (Engl); 2017 Nov; 130(22):2661-2665. PubMed ID: 29133752
[TBL] [Abstract][Full Text] [Related]
27. Preoperative MRI and LDH in women undergoing intra-abdominal surgery for fibroids: Effect on surgical route.
Kim A; Boyd L; Ringel N; Meyer J; Bennett G; Lerner V
PLoS One; 2021; 16(2):e0246807. PubMed ID: 33561167
[TBL] [Abstract][Full Text] [Related]
28. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
29. Is open surgery the solution to avoid morcellation of uterine sarcomas? A systematic literature review on the effect of tumor morcellation and surgical techniques.
Ebner F; Friedl TW; Scholz C; Schochter F; Janni W; Vorwerk E; deGregorio N
Arch Gynecol Obstet; 2015 Sep; 292(3):499-506. PubMed ID: 25716668
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma.
Song KJ; Yu XN; Lv T; Chen YL; Diao YC; Liu SL; Wang YK; Yao Q
Medicine (Baltimore); 2018 Apr; 97(14):e0268. PubMed ID: 29620641
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Accuracy of Ultrasound, Contrast-enhanced CT, and Conventional MRI for Differentiating Leiomyoma From Leiomyosarcoma.
Gaetke-Udager K; McLean K; Sciallis AP; Alves T; Maturen KE; Mervak BM; Moore AG; Wasnik AP; Erba J; Davenport MS
Acad Radiol; 2016 Oct; 23(10):1290-7. PubMed ID: 27396800
[TBL] [Abstract][Full Text] [Related]
32. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
Zurawin RK; Fischer JH; Amir L
J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
[TBL] [Abstract][Full Text] [Related]
33. Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.
Sharma P; Kumar R; Singh H; Jeph S; Sharma JB; Jain SK; Sharma DN; Bal C; Malhotra A
Nucl Med Commun; 2012 Feb; 33(2):185-90. PubMed ID: 22107993
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Challenge: Distinguishing Uterine Fibroid with Cystic Degeneration vs. Ovarian Cystic Malignancy. A Case Report.
Winarto H; Simatupang ONN; Calvin D; Siregar TP; Andrijono
J Radiol Case Rep; 2023 Apr; 17(4):1-12. PubMed ID: 37144233
[TBL] [Abstract][Full Text] [Related]
35. Risk, risk reduction and management of occult malignancy diagnosed after uterine morcellation: a commentary.
Lynam S; Young L; Morozov V; Rao G; Roque DM
Womens Health (Lond); 2015 Nov; 11(6):929-44. PubMed ID: 26673851
[TBL] [Abstract][Full Text] [Related]
36. Leiomyosarcoma of the uterus: ultrasonography and serum lactate dehydrogenase level.
Seki K; Hoshihara T; Nagata I
Gynecol Obstet Invest; 1992; 33(2):114-8. PubMed ID: 1559623
[TBL] [Abstract][Full Text] [Related]
37. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
Mowers EL; Skinner B; McLean K; Reynolds RK
J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
[TBL] [Abstract][Full Text] [Related]
38. Case report: MR imaging features of disseminated uterine leiomyosarcoma presenting after hysterectomy with morcellation.
Ciszak T; Mittal PK; Sullivan P; Cardona K; Hanley KZ; Khanna N; Moreno CC
Abdom Imaging; 2015 Oct; 40(7):2600-5. PubMed ID: 26093623
[TBL] [Abstract][Full Text] [Related]
39. Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children.
Liu TY; Lee WJ; Tsai CM; Kuo KC; Lee CH; Hsieh KS; Chang CH; Su YT; Niu CK; Yu HR
Pediatr Neonatol; 2018 Oct; 59(5):501-506. PubMed ID: 29337082
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery.
Oduyebo T; Hinchcliff E; Meserve EE; Seidman MA; Quade BJ; Rauh-Hain JA; George S; Nucci MR; del Carmen MG; Muto MG
J Minim Invasive Gynecol; 2016 Jan; 23(1):34-9. PubMed ID: 26253281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
